Vimarsana
Biggest News Aggregation in the World

Lori Kunkel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lori Kunkel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lori Kunkel Today - Breaking & Trending Today

Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors - Vimarsana News

Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors

BOULDER, Colo., April 09, 2024 (GLOBE NEWSWIRE) -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage precisio...

ProfoundBio Readies for Next Phase of Growth with Management Team Additions and Advisory Board Appointment - Vimarsana News

ProfoundBio Readies for Next Phase of Growth with Management Team Additions and Advisory Board Appointment

SEATTLE, November 02, 2023--ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate (ADC) therapeutics for cancer, today announced the addition of multiple industry veterans to its leadership team to support its growth.

Source: yahoo.com
K36 Therapeutics Announces FDA Clearance of Investigational New Drug Application and Formation of Clinical Advisory Board for Lead Program KTX-1001 - Vimarsana News

K36 Therapeutics Announces FDA Clearance of Investigational New Drug Application and Formation of Clinical Advisory Board for Lead Program KTX-1001

/PRNewswire/ -- K36 Therapeutics, Inc. ("K36"), a privately held biotechnology company developing novel targeted therapies for the unmet medical needs of...

K36 Therapeutics Launches with $30 Million Series A Financing from F-Prime Capital and Atlas Venture with Eight Roads Ventures - Vimarsana News

K36 Therapeutics Launches with $30 Million Series A Financing from F-Prime Capital and Atlas Venture with Eight Roads Ventures

/PRNewswire/ -- K36 Therapeutics, Inc. ("K36"), a privately held biotechnology company developing breakthrough therapies for the unmet medical needs of cancer...

K36 Therapeutics Launches with $30 Million Series A Financing from F-Prime Capital and Atlas Venture with Eight Roads Ventures - Vimarsana News

K36 Therapeutics Launches with $30 Million Series A Financing from F-Prime Capital and Atlas Venture with Eight Roads Ventures

/PRNewswire/ -- K36 Therapeutics, Inc. ("K36"), a privately held biotechnology company developing breakthrough therapies for the unmet medical needs of cancer...